{"id":"W2003693083","doi":"10.1016/j.rmed.2015.02.012","title":"A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease","year":2015,"lang":"en","type":"article","venue":"Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; COPD; Placebo; Bronchodilator; Anesthesia; Dose-ranging study; Pulmonary function testing; Clinical endpoint; Area under the curve; Pharmacokinetics; Internal medicine; Randomized controlled trial; Asthma; Double blind","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002355071,0.002794503,0.004573975,0.0006797347,0.0006876984,0.001217434,0.001369738,0.002914507,0.006979347],"category_scores_gemma":[0.00246413,0.001288338,0.001841835,0.0004893818,0.002158296,0.00136321,0.0006130391,0.003326375,0.001443207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007511131,"about_ca_system_score_gemma":0.001442466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000594659,"about_ca_topic_score_gemma":0.001157671,"domain_scores_codex":[0.9989574,0.0005003854,0.00007292361,0.000230294,0.00007126002,0.0001678415],"domain_scores_gemma":[0.9982463,0.0004699092,0.0003764249,0.0001818317,0.0001410922,0.0005844412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9806526,0.009517553,0.0002099233,0.000259466,0.0002059819,0.00002424178,0.00003803826,0.0001367216,0.00449021,0.00003438188,0.0002235564,0.004207342],"study_design_scores_gemma":[0.9261874,0.072584,0.0005812962,0.000008562233,0.00008546803,0.00001168717,0.000007821158,0.0001013432,0.0002360368,0.00003194855,0.0001567711,0.000007570166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98537,0.002081192,0.00086919,0.0006002371,0.0007335952,0.007863541,0.0009802495,0.0001626278,0.001339299],"genre_scores_gemma":[0.9709919,0.002001213,0.003025186,0.001581243,0.0008961161,0.01475603,0.001669761,0.00004684129,0.005031557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006979347,"threshold_uncertainty_score":0.02334821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03866285701502193,"score_gpt":0.3217502101785243,"score_spread":0.2830873531635024,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}